glp-1 receptor agonists blindness risk Ozempic Blindness: Should You Worry? GLP-1 Receptor Agonists for the

Curr Opin Endocrinol Diabetes Obes

Patients differ in how they process and store energy, build or lose muscle, and respond to changes in appetite or activity

Deficiencies are rare but can cause brittle hair and nails

Holistic care management Although much of the current cultural discourse about GLP-1s is related to how the medications are used to manage weight, the fact of the matter is most patients (the KFF survey said around six in 10) are taking them to manage diabetes and heart disease

While most hydration challenges on GLP-1 therapy can be managed with increased fluid intake and dietary modifications, certain situations require prompt medical evaluation to prevent serious complications or identify underlying issues requiring treatment adjustment

Last weeks JAMA had two articles on GLP-1 drugs that point to their promise for treatment of diseases beyond the conditions for which they are already approved by the FDA: obesity, diabetes, cardiovascular risk, sleep apnea and metabolic liver disease